Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Halozyme Therapeutics strengthens management team

This article was originally published in Scrip

Executive Summary

Halozyme Therapeutics, a US biopharmaceutical company developing and commercialising products targeting the extracellular matrix for the drug delivery, metabolism, oncology, and dermatology markets, has appointed Dr Patrick O'Connor vice-president of research, Dr Michael LaBarre vice-president of product development, and James Cartoni vice-president of legal. Dr O'Connor joins from Ardea Biosciences, where he was senior vice-president and chief scientific officer. Dr LaBarre previously served as vice-president of product development at Paramount BioSciences, while Mr Cartoni was a partner at the law firm DLA Piper.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC007169

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel